SILVER SPRING, Maryland – The U.S. Food and Drug Administration late Friday afternoon approved emergency use of Pfizer Inc. and its German partner BioNTech’s vaccine.
The emergency use authorization allows the Pfizer-BioNTech COVID-19 Vaccine to be distributed in the U.S. The FDA approval kicks off a massive logistics effort by package delivery companies FedEx and UPS under the direction of the Pentagon’s ‘Operation Warp Speed’ officials to initially deliver nearly 3 million doses of the vaccine to more than 600 sites nationwide.
The FDA action comes just the day after the FDA’s advisory panel voted 17-4 in favour of recommending emergency approval of distribution of the vaccine.
Read more on losangelesblade.com